Natera, Inc. (NTRA)
410.35
+1.88
(+0.46%)
USD |
NASDAQ |
Oct 02, 16:00
410.01
-0.34
(-0.08%)
After-Hours: 20:00
Natera Enterprise Value : 58.08B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 58.08B |
| October 01, 2026 | 57.81B |
| September 30, 2026 | 58.50B |
| September 29, 2026 | 58.68B |
| September 28, 2026 | 58.28B |
| September 25, 2026 | 58.40B |
| September 24, 2026 | 57.85B |
| September 23, 2026 | 55.27B |
| September 22, 2026 | 55.28B |
| September 21, 2026 | 52.38B |
| September 18, 2026 | 52.20B |
| September 17, 2026 | 51.75B |
| September 16, 2026 | 48.74B |
| September 15, 2026 | 49.52B |
| September 14, 2026 | 48.23B |
| September 11, 2026 | 46.39B |
| September 10, 2026 | 45.98B |
| September 09, 2026 | 46.58B |
| September 08, 2026 | 45.70B |
| September 04, 2026 | 46.28B |
| September 03, 2026 | 46.20B |
| September 02, 2026 | 45.84B |
| September 01, 2026 | 45.21B |
| August 31, 2026 | 45.38B |
| August 28, 2026 | 46.00B |
| Date | Value |
|---|---|
| August 27, 2026 | 47.79B |
| August 26, 2026 | 47.75B |
| August 25, 2026 | 47.50B |
| August 24, 2026 | 46.21B |
| August 21, 2026 | 46.83B |
| August 20, 2026 | 45.80B |
| August 19, 2026 | 45.83B |
| August 18, 2026 | 43.91B |
| August 17, 2026 | 44.27B |
| August 14, 2026 | 43.66B |
| August 13, 2026 | 43.78B |
| August 12, 2026 | 44.52B |
| August 11, 2026 | 44.06B |
| August 10, 2026 | 44.87B |
| August 07, 2026 | 45.40B |
| August 06, 2026 | 37.26B |
| August 05, 2026 | 38.59B |
| August 04, 2026 | 38.67B |
| August 03, 2026 | 37.97B |
| July 31, 2026 | 37.60B |
| July 30, 2026 | 37.87B |
| July 29, 2026 | 35.60B |
| July 28, 2026 | 35.37B |
| July 27, 2026 | 36.20B |
| July 24, 2026 | 36.77B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Guardant Health, Inc. | 24.40B |
| Myriad Genetics, Inc. | 529.32M |
| CareDx, Inc. | 3.103B |
| Caris Life Sciences, Inc. | 7.656B |
| BioRestorative Therapies, Inc. | -0.8314M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -66.97M |
| Revenue (Quarterly) | 752.75M |
| Total Expenses (Quarterly) | 819.72M |
| EPS Diluted (Quarterly) | -0.4674 |
| Gross Profit Margin (Quarterly) | 63.70% |
| Profit Margin (Quarterly) | -8.90% |
| Earnings Yield | -0.33% |
| Normalized Earnings Yield | -0.3287 |